RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @rsloftx: $nwbo #nwbo $dcvax #dcvax #murcidencel

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @apwriter: $nwbo

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @EveryTrade: $NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @EveryTrade: $NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @EveryTrade: $NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

https://t.co/GJR6YJayZ0 $nwbo @alphavestcap

NCI Neuro-Oncology Branch @NIHBrainTumor Today.. Liau of @UCLANsgy. '22, Dr. Liau published a phase 3 study in @JAMAOnc, investigating if dc vax L.. added ... to standard of care extends survival in glioblastoma patients: https://t.co/OGaOxGg45B $nwbo @al

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @DocOck222: Dr. Linda Liau is an American Hero !!!! 🦸🏻‍♀️🇺🇸 👩🏻‍⚕️

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @DocOck222: Dr. Linda Liau is an American Hero !!!! 🦸🏻‍♀️🇺🇸 👩🏻‍⚕️

$NWBO #DCVax

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

$nwbo

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @EveryTrade: $NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

Dr. Linda Liau is an American Hero !!!! 🦸🏻‍♀️🇺🇸 👩🏻‍⚕️

RT @EveryTrade: $NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

Welcome to the NCI, Dr. Liau. $NWBO

RT @EveryTrade: $NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

$NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investigating if adding autologous tumor lysate-loaded dendritic cell vaccine to standard of care extends survival in glioblastoma patients: htt

RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…

RT @sharpie510: @ourbrainbank Dr. Steven Brem is a co-author of the phase 3 #DCVax-L paper published in @JAMAOnc. Looking forward to an upd…

RT @sharpie510: @ourbrainbank Dr. Steven Brem is a co-author of the phase 3 #DCVax-L paper published in @JAMAOnc. Looking forward to an upd…

RT @sharpie510: @ourbrainbank Dr. Steven Brem is a co-author of the phase 3 #DCVax-L paper published in @JAMAOnc. Looking forward to an upd…

RT @sharpie510: @ourbrainbank Dr. Steven Brem is a co-author of the phase 3 #DCVax-L paper published in @JAMAOnc. Looking forward to an upd…

@ourbrainbank Dr. Steven Brem is a co-author of the phase 3 #DCVax-L paper published in @JAMAOnc. Looking forward to an update. #Hope4Patients The DCVax® Platform For All Solid Tumor Cancers $nwbo #glioblastoma #CancerMoonshot @POTUS @FLOTUS @NIHDirector

RT @shawna11lee: $nwbo 👏🏻🚀🤍

RT @MonsonVO: Go $NWBO in your regulatory approval of DCVax for both solo treatment and combination treatment as discussed in this article.…

RT @MonsonVO: Go $NWBO in your regulatory approval of DCVax for both solo treatment and combination treatment as discussed in this article.…

RT @MonsonVO: Go $NWBO in your regulatory approval of DCVax for both solo treatment and combination treatment as discussed in this article.…

RT @MonsonVO: Go $NWBO in your regulatory approval of DCVax for both solo treatment and combination treatment as discussed in this article.…

RT @MonsonVO: Go $NWBO in your regulatory approval of DCVax for both solo treatment and combination treatment as discussed in this article.…

RT @MonsonVO: Go $NWBO in your regulatory approval of DCVax for both solo treatment and combination treatment as discussed in this article.…

Go $NWBO in your regulatory approval of DCVax for both solo treatment and combination treatment as discussed in this article. I find it interesting that the focus of the preprint is on research funded by the government and supported by the National Library

RT @Kenneth83risom: $nwbo this gets better every time reading it. https://t.co/nDN1q5N4FG https://t.co/FCv9ZQQbXJ https://t.co/Tc2MrbjbqU

$nwbo this gets better every time reading it. https://t.co/nDN1q5N4FG https://t.co/FCv9ZQQbXJ https://t.co/Tc2MrbjbqU

$NWBO Shareholders please put this by your nite stand! Anything negative about #DCVAX-L, then whip this out because these here are Facts. The whole truth and nothing but the truth!

RT @flaskworks: @elkwood66 @tammy_pack80417 @HAMShortkiller @GaryGensler @HesterPeirce Interesting when anon edgelords seek to undermine $N…

RT @flaskworks: @elkwood66 @tammy_pack80417 @HAMShortkiller @GaryGensler @HesterPeirce Interesting when anon edgelords seek to undermine $N…

@elkwood66 @tammy_pack80417 @HAMShortkiller @GaryGensler @HesterPeirce Interesting when anon edgelords seek to undermine $NWBO as overwhelming evidence suggests DCVax will drastically change oncology. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJWn http

@The_Wayne_Kerr @andrewcaravello https://t.co/V86zey58Hi 🙂

RT @alphavestcap: https://t.co/eftme6uFNC https://t.co/bhUDKROm2Z 13% alive on dc vax l at 5 years per JAMA 11/27/22 paper . 38/300 alive a…

https://t.co/eftme6uFNC https://t.co/bhUDKROm2Z 13% alive on dc vax l at 5 years per JAMA 11/27/22 paper . 38/300 alive at 8-10 years per Zivic . Sounds like if the patient on DC VAX L makes it to 5 years, he's-she's cured.

RT @flaskworks: @BiotechCH @Seals310 @YaronWerber Nothing about $NWBO's DCVax featured in JAMA, upcoming in Nature, with imminent MHRA MAA…

https://t.co/Eew3eseSen $nwbo @alphavestcap

Excitement building for $NWBO and #DCVax - MAA submission likely within the next 2 weeks, Dr. Linda Liau on the SAB - LOTS of short term positive catalysts for this one! Don't take my word for it: https://t.co/Sk1LV2JhTT

RT @flaskworks: @noMidwestHedgie Your obsessive-compulsive fixation with defaming $NWBO clearly results from your mental disorder (asperger…

@biotech44 @JAMAOnc $NWBO $XBI $IBB https://t.co/Ji6ltP29NJ https://t.co/gycKpedYxd

@noMidwestHedgie Your obsessive-compulsive fixation with defaming $NWBO clearly results from your mental disorder (aspergers) as no rational human being would reach these ridiculous conclusions. https://t.co/UbQi4GbIF9 https://t.co/NDF2KDCG6C https://t.

@noMidwestHedgie @metacollectiveG Overall survival for $NWBO's DCVax clear. If your cognitive antisocial disorder causes you to engage in obsessive compulsive behavior, defamation, and lose millions shorting @NorthwestBio, well that's your problem not our

https://t.co/Eew3eseSen $nwbo @alphavestcap

RT @flaskworks: @BiotechCH @Seals310 @YaronWerber Nothing about $NWBO's DCVax featured in JAMA, upcoming in Nature, with imminent MHRA MAA…

@BiotechCH @Seals310 @YaronWerber Nothing about $NWBO's DCVax featured in JAMA, upcoming in Nature, with imminent MHRA MAA submission in the UK. Does #BiotechHangout really know what's happening in the industry they claim to cover? https://t.co/UbQi4GbIF

RT @flaskworks: @nut_history He needs @NorthwestBio DCVax! https://t.co/UbQi4GbIF9 https://t.co/NDF2KDCG6C https://t.co/I8vNcCGIUR

@nut_history He needs @NorthwestBio DCVax! https://t.co/UbQi4GbIF9 https://t.co/NDF2KDCG6C https://t.co/I8vNcCGIUR